Skip to main content

Find Clinical Trials

Home
Conditions
BRCA1-Associated Protein-1 (BAP1) Mutations

Clinical trial condition

BRCA1-Associated Protein-1 (BAP1) Mutations

Explore clinical trials studying BRCA1-Associated Protein-1 (BAP1) Mutations. Study availability and eligibility vary by location and protocol.

2 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

BRCA1-Associated Protein-1 (BAP1) Mutations trial results

Recruiting

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

NCT04431024

Conditions: Adenoma, BRCA1-Associated Protein-1 (BAP1) Mutations, Familial Cancer, +6 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma

NCT05960773

Conditions: Adenoma, BRCA1-Associated Protein-1 (BAP1) Mutations, Early-stage BAP1-associated Malignancies, +16 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details